Abstract
We report the burden of risk factors in cerebral venous sinus thrombosis (CVST) and its relationship with the clinical severity, extent of MRI and MRV abnormality, and outcome. One hundred and twenty-eight consecutive patients with CVST were included. Their demographic, presenting symptoms and neurological findings were noted and risk factors of CVST were evaluated. The outcomes were assessed using modified Rankin Scale (mRS). Based on the risk factors, the patients could be categorized as prothrombotic conditions only in 46 (35.9%), prothrombotic with other risk factors in 36 (28.1%), non-prothrombotic risk factors in 20 (15.6%), and no risk factors in 26 (20.3%). More than two risk factors were present in 33 (25.8%). Sixteen out of 22 (72.7%) patients with female gender-specific risk factors also had other prothrombotic conditions. On MRV, more than two sinuses were involved in 35 (27.3%) patients and 94 (73.4%) patients had parenchymal lesions on MRI. Thirty-one (24.2%) patients had poor outcome (mRS > 2) at discharge and 25/122 (20.5%) at 3 months. The number of risk factors was not related to clinical severity and extent of MRI or MRV abnormality. On multivariate analysis, age (OR 1.05, 95%CI 1.00–1.09, P = 0.03), GCS score (OR 5.30, 95%CI 1.25–22.24, P = 0.02), and mechanical ventilation (OR 196.17, 95%CI 16.05, P = 0.001) predicted the outcome at 3 months.
Similar content being viewed by others
References
Kimber J. Cerebral venous sinus thrombosis. QJM. 2002;95(3):137–42. https://doi.org/10.1093/qjmed/95.3.137.
Chopra JS, Banerjee AK. Primary intracranial sinovenous occlusions in youth and pregnancy. In: Toole JF, editor. Handbook of clinical neurology, vascular disease part II, vol. 54. North Holland: Elsevier; 1989. p. 425–52.
Kalita J, Bansal V, Misra UK, Phadke RV. Cerebral venous sinus thrombosis in a tertiary care setting in India. QJM. 2006;99(7):491–2. https://doi.org/10.1093/qjmed/hcl068.
Kalita J, Chandra S, Kumar B, Bansal V, Misra UK. Cerebral venous sinus thrombosis from a tertiary care teaching Hospital in India. Neurologist. 2016;21(3):35–8. https://doi.org/10.1097/NRL.0000000000000079.
de Bruijn SF, Stam J, Koopman MM, Vandenbroucke JP. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in carriers of hereditary prothrombotic conditions. The cerebral venous sinus thrombosis study group. BMJ. 1998;316(7131):589–92. https://doi.org/10.1136/bmj.316.7131.589.
Gadelha T, André C, Jucá AA, Nucci M. Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis. Cerebrovasc Dis. 2005;19(1):49–52. https://doi.org/10.1159/000081911.
Koopman K, Uyttenboogaart M, Vroomen PC, van der Meer J, De Keyser J, Luijckx GJ. Development and validation of a predictive outcome score of cerebral venous thrombosis. J Neurol Sci. 2009;276(1–2):66–8. https://doi.org/10.1016/j.jns.2008.08.033.
Barinagerrementeria F, Carlos C, Arrendondo H. Aseptic cerebralvenous thrombosis: proposed prognostic scale. J Stroke Cerebrovasc Dis. 1992;2(1):34–9. https://doi.org/10.1016/S1052-3057(10)80032-1.
Ferro JM, Bacelar-Nicolau H, Rodrigues T, Bacelar-Nicolau L, Canhão P, Crassard I, et al. Risk score to predict the outcome of patients with cerebral vein and dural sinus thrombosis. Cerebrovasc Dis. 2009;28(1):39–44. https://doi.org/10.1159/000215942.
Zubkov AY, McBane RD, Brown RD, Rabinstein AA. Brain lesions in cerebral venous sinus thrombosis. Stroke. 2009;40(4):1509–11. https://doi.org/10.1161/STROKEAHA.108.529172.
Girot M, Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, et al. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke. 2007;38(2):337–42. https://doi.org/10.1161/01.STR.0000254579.16319.35.
Kalita J, Chandra S, Misra UK. Significance of seizure in cerebral venous sinus thrombosis. Seizure. 2012;21(8):639–42. https://doi.org/10.1016/j.seizure.2012.07.005.
Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45. London: Her Majesty’s Stationary Office; 1976.
Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, American Heart Association Stroke Council and the Council on Epidemiology and Prevention, American Heart Association Stroke Council and the Council on Epidemiology and Prevention, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158–92. https://doi.org/10.1161/STR.0b013e31820a8364.
Misra UK, Kalita J, Chandra S, Kumar B, Bansal V. Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial. Eur J Neurol. 2012;19(7):1030–6. https://doi.org/10.1111/j.1468-1331.2012.03690.x.
Misra UK, Kalita J, Mani VE. Neurological manifestations of scrub typhus. J Neurol Neurosurg Psychiatry. 2015;86(7):761–6. https://doi.org/10.1136/jnnp-2014-308722.
Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and Dural sinus thrombosis (ISCVT). Stroke. 2004;35(3):664–70. https://doi.org/10.1161/01.STR.0000117571.76197.26.
Meng Q, Pu C. Cerebral venous thrombosis and factor V Leiden mutation. Zhonghua Yi Xue Za Zhi. 2002;82(1):47–9.
Weih M, Vetter B, Ziemer S, et al. Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis. J Neurol. 1998;245(3):149–52. https://doi.org/10.1007/s004150050195.
Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, et al. Prothrombin gene G20210—a transition is a risk factor for cerebral venous thrombosis. Stroke. 1998;29(9):1765–9. https://doi.org/10.1161/01.STR.29.9.1765.
Ventura P, Cobelli M, Marietta M, Panini R, Rosa MC, Salvioli G. Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis. Cerebrovasc Dis. 2004;17(2–3):153–9. https://doi.org/10.1159/000075784.
Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood. 2006;107(7):2766–73. https://doi.org/10.1182/blood-2005-09-3578.
Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood. 2003;102(4):1363–6. https://doi.org/10.1182/blood-2003-02-0443.
Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol. 2002;70(2):126–32. https://doi.org/10.1002/ajh.10103.
Christopher R, Nagaraja D, Dixit NS, Narayanan CP. Anti cardiolipin antibodies: a study in cerebral venous thrombosis. Acta Neurol Scand. 1999;99(2):121–4. https://doi.org/10.1111/j.1600-0404.1999.tb00669.x.
Khealani BA, Wasay M, Saadah M, Sultana E, Mustafa S, Khan FS, et al. Cerebral venous thrombosis: a descriptive multicenter study of patients in Pakistan and Middle East. Stroke. 2008;39(10):2707–11. https://doi.org/10.1161/STROKEAHA.107.512814.
Azin H, Ashjazadeh N. Cerebral venous sinus thrombosis—clinical features, predisposing and prognostic factors. Acta Neurol Taiwanica. 2008;17(2):82–7.
Acknowledgements
We thank Mr. Shakti Kumar for the secretarial help.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of Interest
The authors declare that they have no conflict of interest.
Informed Consent
None.
Research Involving Human Participants and/or Animals
Observational study, involves routine management.
Ethical Approval
This study was approved by the Institutional Ethics Committee (PGI/BE/774).
Additional information
Highlights:
• Prothrombotic state is the commonest cause of CVST (64%).
• Twenty percent patients may not have risk factor.
• Multiple risk factors were more frequent than single risk factor for occurrence of CVST.
• Burden of risk factors does not determine clinico-radiological severity and outcome.
• Need for mechanical ventilation, GCS score and elderly patients were independent predictors for poor clinical outcome.
Rights and permissions
About this article
Cite this article
Kalita, J., Misra, U.K. & Singh, R.K. Do the Risk Factors Determine the Severity and Outcome of Cerebral Venous Sinus Thrombosis?. Transl. Stroke Res. 9, 575–581 (2018). https://doi.org/10.1007/s12975-017-0607-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12975-017-0607-6